Manjit Kooner's journey with Myelodysplastic Syndrome (MDS) has been a challenging one, marked by strength, resilience, and ...

Faron Pharmaceuticals Ltd | Company announcement | March 03, 2025 at 14:00:00 EET Inside Information: FDA Grants Orphan Drug Designation for Bexmarilimab in MDS Key highlightsOrphan Drug Designation f ...

Pediatric bone marrow myelofibrosis (MF) is a rare and complex hematological disorder characterized by cytopenia, bone marrow fibrosis, and systemic ...

Developing effective therapies for MDS has been made difficult by their relative infrequency and by the heterogeneity in the natural history of these diseases. The clinical course of childhood MDS ...

The trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.

PRGN-2012—which Precigen has begun to call by its generic name of zopapogene imadenovec—is a gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus ...

WELLESLEY HILLS, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of ...

Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...